Last updated 2026-06-18
- Acquired by Orgenesis, Mar 2025
Total raised
—
Stage
Acquired
Founded
2018
Headcount
0
HQ
Tel Aviv-Yafo, Israel
Sector
Health Tech & Life Sciences
About
Neurocords is developing regenerative therapies for spinal cord injuries. Its focus is on a novel cellular therapy platform aimed at restoring function following spinal cord injuries.
Q&A
- What is Neurocords' primary focus?
- Neurocords is developing regenerative therapies for spinal cord injuries, specifically focusing on a novel cellular therapy platform to restore function.
- When was Neurocords founded?
- Neurocords was founded in March 2018.
- What is the current status of Neurocords?
- Neurocords is currently active, having been acquired by Orgenesis in March 2025.
- Where is Neurocords headquartered?
- Neurocords is headquartered in Tel Aviv-Yafo, Israel.
- What is Neurocords' primary sector classification?
- Neurocords' primary sector classification is Health Tech & Life Sciences.
- What business model does Neurocords primarily use?
- Neurocords primarily operates with a B2B business model.
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical Biotechnology
Business model
B2B
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
Identifiers & details
| Founded | 2018-3 |
|---|---|
| Status reason | Acquired by Orgenesis on Mar, 2025 |
Acquisitions & public offerings
Acquired by Orgenesis 2025-03